Molecule Information
General Information of the Molecule (ID: Mol04184)
| Name |
microRNA-99b-5p (miR-99b-5p)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
microRNA 99b
Click to Show/Hide
|
||||
| Molecule Type |
Mature miRNA
|
||||
| Sequence |
CACCCGUAGAACCGACCUUGCG
Click to Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Mature Accession | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | MDA PCa 2b cells | Prostate | Homo sapiens (Human) | CVCL_4748 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-10p overexpression results in suppressing nuclear translocation of | |||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | PC-3 cells | Bone | Homo sapiens (Human) | CVCL_0035 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-5p overexpression results in suppressing nuclear translocation of | |||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | DU145 cells | Prostate | Homo sapiens (Human) | CVCL_0105 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-6p overexpression results in suppressing nuclear translocation of | |||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | LNCaP cells | Prostate | Homo sapiens (Human) | CVCL_0395 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-7p overexpression results in suppressing nuclear translocation of | |||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | 22Rv-1 cells | Prostate | Homo sapiens (Human) | CVCL_1045 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-8p overexpression results in suppressing nuclear translocation of | |||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Sensitive Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Sensitive Drug | Enzalutamide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | HIF-1 signaling pathway | Activation | hsa04066 | |
| VEGF signaling pathway | Activation | hsa04370 | ||
| In Vitro Model | C4-2B cells | Prostate | Homo sapiens (Human) | CVCL_4784 |
| Experiment for Molecule Alteration |
qRT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Colony formation assay | |||
| Mechanism Description | On the other hand, overexpression of miR-99b-5p (i.e. via transfection of miR-99b-5p mimic) targets/inhibits AR, mTOR and SMARCD1 simultaneously and blocks the translocation of mTOR/AR/SMARCD1 complex from cytoplasm to nucleus, consequently suppressing cell proliferation/survival and enhancing the cell apoptosis in PCa (especially AA PCA and CRPC). Furthermore, miR-99b-9p overexpression results in suppressing nuclear translocation of | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
